Employer profile
Viridian Therapeutics
3 certified H-1B filings across 1 fiscal year.
FY2025 filings
3
FY2025 median
$156k
Top role
Clinical Trial Manager
1 filings · all-time
Top state
MA
3 filings · all-time
Pay distribution
How Viridian Therapeutics pays, by fiscal year
Each box is the p25–p75 interquartile range; the heavy line is the median and the whiskers reach p10–p90. Base salary only — hover a year for its figures.
Year-over-year
How Viridian Therapeutics hired across H-1B fiscal years. The small figure under each filings count is its change vs the prior FY.
| FY | Filings | Median $ |
|---|---|---|
| FY2025 | 3— | $156k |
Prevailing wage level distribution
DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.
Lvl ?
267%
Lvl IV
133%
Top job titles
Most-filed positions, across all years (raw DOL titles).
| Job Title | Filings | Median |
|---|---|---|
| Clinical Trial Manager | 1 | $156k |
| Director, R&D Quality Pv | 1 | $220k |
| Senior Manager, Qc Tech Services Systems | 1 | $145k |
Top worksite states
Where this employer files.
| State | Filings | Median |
|---|---|---|
| MA | 3 | $156k |
Related employers
Similar H-1B volume
Frequently asked questions
- How much does Viridian Therapeutics pay H-1B workers?
- Viridian Therapeutics's median certified H-1B base salary is $156k (FY2025), from 3 filings. See the full salary distribution and percentiles above.
- How many H-1B workers does Viridian Therapeutics sponsor?
- Viridian Therapeutics has 3 certified H-1B Labor Condition Applications on record (FY2025).
- What jobs does Viridian Therapeutics sponsor for H-1B?
- Viridian Therapeutics's most-sponsored H-1B roles include Clinical Trial Manager, Director, R&D Quality Pv, Senior Manager, Qc Tech Services Systems.
- Where does Viridian Therapeutics hire H-1B workers?
- Viridian Therapeutics's top H-1B worksite states are MA.
Calculate your H-1B lottery odds →orCheck out the insights →